Announcements Trials

Browse Landscape

Phase

Phase 1 3 Phase EARLY_PHASE1 2 Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Colorectal Neoplasms 7 Prostatic Neoplasms 6 Urinary Bladder Neoplasms 5 Leukemia, Myeloid, Acute 5 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Lung Neoplasms 4 Glioblastoma 4 Triple Negative Breast Neoplasms 3 Mouth Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Uterine Cervical Neoplasms 2 Ureteral Neoplasms 2 Stomatitis 2 Recurrence 2 Oropharyngeal Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 COVID-19 2 Brain Neoplasms 2 Adenocarcinoma 2

Interventions

Temozolomide 69 Bevacizumab 40 Radiotherapy 22 Magnetic Resonance Spectroscopy 20 Irinotecan 17 Specimen Handling 10 Carboplatin 10 Carmustine 9 X-Rays 7 Radiation 7 olaparib 6 Surgical Procedures, Operative 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 Nivolumab 6 Everolimus 6 Cyclophosphamide 6 Biopsy 6 trametinib 5 Thalidomide 5 Cisplatin 5 pembrolizumab 4 palbociclib 4 fluorodopa F 18 4 erdafitinib 4 dabrafenib 4 Lomustine 4 Etoposide 4 Drug Therapy 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioma × Standard of Care × Clear all

NCT04209790 2025-11-10

NeoGlio

Geisinger Clinic

Phase 2 Terminated

2 enrolled 7 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡